Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04169282 · ClinicalTrials.gov registry record · NA
PEEP Mask for Tracheobronchomalacia-Induced Cough
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04169282 is a NA study that has completed, run by Duke University. The registered enrollment target is 10 participants.
The verdict
NCT04169282, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study aims to determine if an expiratory resistance device that delivers non-invasive positive expiratory pressure (nPEP) will reduce or stop coughing, reduce airway resistance and improve quality of life in patients with tracheobronchomalacia (TBM) who are not candidates for tracheal stenting.
Interventions
- DEVICE nPEP (non-invasive positive expiratory pressure) mask
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-08-30 |
| Est. Completion | 2022-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04169282
The ClinicalTrials.gov registry entry for NCT04169282 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which nPEP (non-invasive positive expiratory pressure) mask is the first listed.
NCT04169282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04169282 about?
NCT04169282 is a clinical study titled "PEEP Mask for Tracheobronchomalacia-Induced Cough". This study aims to determine if an expiratory resistance device that delivers non-invasive positive expiratory pressure (nPEP) will reduce or stop coughing, reduce airway resistance and improve quality of life in patients with tracheobronchomalacia (TBM) who are not candidates for tracheal stenting.
What is the current status of trial NCT04169282?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-08-30. Estimated completion is 2022-08-15.
What interventions are being tested in trial NCT04169282?
The interventions under investigation include: nPEP (non-invasive positive expiratory pressure) mask (DEVICE).
Who is sponsoring clinical trial NCT04169282?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.